CN1806820A - Chinese medicinal composition, preparation method and quality control method thereof - Google Patents
Chinese medicinal composition, preparation method and quality control method thereof Download PDFInfo
- Publication number
- CN1806820A CN1806820A CN 200510200043 CN200510200043A CN1806820A CN 1806820 A CN1806820 A CN 1806820A CN 200510200043 CN200510200043 CN 200510200043 CN 200510200043 A CN200510200043 A CN 200510200043A CN 1806820 A CN1806820 A CN 1806820A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- solution
- chinese medicine
- medicine composition
- adds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention discloses a traditional Chinese medicinal composition for treating traumatic injuries, which is prepared from safflower, wood louse, cinnabar, seed of nuxvomica powder, myrrh, notoginseng, starfish, Canton love-pea vine, boneol, native copper, mastiche and sweet melon seeds by a predetermined proportion. The invention discloses the method for preparing the Chinese medicinal composition and its quality control method.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition and preparation method thereof, particularly relate to a kind of Chinese medicine composition for the treatment of traumatic injury and preparation method thereof, belong to the field of Chinese medicines.
Background technology
As everyone knows, the related cause of disease of Bone injury disease is how relevant with wound, and its pathogenesis mostly is blood stasis and two aspects of blood deficiency, the patient hindered the back one, two, lie up, and how with fever of the body, aversion to cold, poor appetite, abdominal distention, stightly hard stool such as are not difficult to resolve at symptom,, caused by energy stagnation and blood stasis impaired for muscles and bones.Clinical in recent years and experimentation also shows, symptoms such as pain, heating appear in fracture in early days, mainly be because local vascular permeability increase after the wound, inflammatory tissue oozes out etc. and to cause, effects such as the medicine for the treatment of above symptom should have the gastrointestinal motility of promotion, reduce vascular permeability, reduce that inflammation is oozed out, antibiotic, antiendotoxin and removing free radical.For asthenic cold type lumbago and skelalgia patient, because of clinical manifestation except that symptom such as lumbago and skelalgia is arranged, mainly contain aversion to cold and cold limbs, and the back sx of suffering from cold, get the symptom that warm pain can subtract, so think that it is being experienced in wind, cold, the damp, especially with the cold-evil for very, because of the cold-evil sluggish, it follows through passing on from one to another, so cause pain, the medicine of treatment should have nourishing blood and promoting blood circulation, the effect of dispelling cold by warming the meridian.Invent the Chinese medicine preparation of diseases such as a kind of effective set a broken bone according to the pathogenesis of bone disease, significant.
The object of the invention is to provide a kind of Chinese medicine composition for the treatment of traumatic injury and preparation method thereof; The object of the invention also is to provide a kind of method of quality control of Chinese medicine composition.
Summary of the invention
The objective of the invention is to be achieved through the following technical solutions:
This Chinese medicine composition is to be made by the crude drug of following weight ratio:
Flos Carthami 5-15 weight portion Eupolyphaga Seu Steleophaga 30-50 weight portion Cinnabaris 5-15 weight portion
Semen Strychni Pulveratum 15-30 weight portion Myrrha 3-6 weight portion Radix Notoginseng 60-100 weight portion
Asterias amurensis Lutken 15-30 weight portion Os Gallus domesticus 30-60 weight portion Borneolum Syntheticum 1-3 weight portion
Pyritum 15-30 weight portion Olibanum 1-5 weight portion Semen Melo 1-5 weight portion.
Definitely, the weight ratio of these crude drug is:
Flos Carthami 12 weight portion Eupolyphaga Seu Steleophagas 40 weight portion Cinnabaris 10 weight portions
Semen Strychni Pulveratum 20 weight portion Myrrhas 4 weight portion Radix Notoginseng 80 weight portions
Asterias amurensis Lutken 20 weight portion Os Gallus domesticus 40 weight portion Borneolum Syntheticums 2 weight portions
Pyritum 20 weight portion Olibanums 4 weight portion Semen Melos 4 weight portions.
This wherein, Myrrha, Asterias amurensis Lutken, Os Gallus domesticus, Pyritum and Olibanum should be respectively Myrrha (processed), Asterias amurensis Lutken (processed), Os Gallus domesticus (processed), Pyritum (calcined) and Olibanum (processed).
In conjunction with the modern Chinese medicine preparation process, more than prescription should be made clinical required various dosage forms, comprises granule, capsule and pill.The inventor writes out a prescription at this, studies, and makes suitable preparation technology, extracts refining and preparations shaping two parts before being divided into.
First: preceding extraction is refining, can have following two kinds to extract process for purification at prescription
1) will write out a prescription in Flos Carthami and starch 4 weight portions, add water and make pasty state, mix thoroughly, dry back be a fine powder with Radix Notoginseng, Asterias amurensis Lutken, Eupolyphaga Seu Steleophaga, Os Gallus domesticus, Pyritum, Olibanum, Myrrha, Semen Melo jointly, mistake 100 mesh sieves are standby.Cinnabaris is worn into impalpable powder, cross 160 mesh sieves.With Semen Strychni Pulveratum, Cinnabaris powder, in the prescription ratio, be blended in the standby fine powder of all medicines, fully mix homogeneously is granulated, and adds Borneolum Syntheticum during granulate, and mixing makes mixture.
2) above flavour of a drug with Eupolyphaga Seu Steleophaga, Pyritum, Olibanum, Myrrha, be fine powder jointly, are crossed 100 mesh sieves, and are standby.Cinnabaris is worn into impalpable powder, cross 160 mesh sieves, standby.Flos Carthami, Radix Notoginseng, Asterias amurensis Lutken, Os Gallus domesticus, Semen Melo are ground into coarse granule, decoct with water twice, each 2 hours, to filter, filtrate merges, and is evaporated to the thick paste of 1.30 ℃ of relative densities, drying under reduced pressure, the gained dried cream powder is broken into fine powder, crosses 100 mesh sieves.With three parts of abundant mix homogeneously of fine powder, granulate, add Borneolum Syntheticum during granulate, mixing makes mixture.
Second portion: preparations shaping, be extracted as the basis with back, the mixture that makes adds corresponding conventional adjuvant just can make clinical required various dosage forms, comprises granule, capsule and pill etc.The inventor has carried out preferably at partial supplementary material wherein.
1) screening of binding agent in the conventional adjuvant
Different concentration ethanol, water, starch slurry, dextrin, high-purity dextrin slurry, starch mixes slurry with sucrose, starch mixes slurry with arabic gum, mucialga of arabic gummy, syrup, maltose, gelatine size, polyvinylpyrrolidone, Polyethylene Glycol, methylcellulose, sodium carboxymethyl cellulose, ethyl cellulose, hydroxypropyl cellulose, sucrose dextrin copolymer is a typical binders, Chinese medicine composition of the present invention, the most former powder of medicine is used as medicine, mealiness is strong, be difficult for granulating, when wet granulation, should select cohesive binding agent preferably, with the high-efficiency binder hydroxypropyl cellulose is example, carry out the binding agent screening, and be index with the granule character, determine best binding agent.The results are shown in following table:
Binder dosage is investigated table as a result
| Binding agent | Character |
| 0.1 50% alcoholic solution of～0.5% hypromellose | Stickiness is little, is difficult for granulating, and can't granulate |
| 50% alcoholic solution of 1～2% hypromellose | Granulate easily, the granule that makes is better |
| 2.5 50% alcoholic solution of～4% hypromellose | The granule of making is harder, and particle shape is bad |
Result of the test shows the 50% alcoholic solution granulation of Chinese medicine composition of the present invention with 1 ~ 2% hypromellose, and the granule particle shape that makes is good, easily makes capsule, granule.
2) screening of lubricant in the conventional adjuvant
Stearic acid and calcium thereof, magnesium, zinc salt, micropowder silica gel, hydrogenated vegetable oil, sodium laurylsulfate, magnesium laurylsulfate, single Laurel sucrose acid ester, adipic acid, fumaric acid, triacetyl glycerine, Macrogol 4000, polyethylene glycol 6000, Polyethylene Glycol 8000, polyoxyethylene monostearate, light mineral oil, liquid Paraffin, the wax class, boric acid, sodium chloride, sodium benzoate, sodium acetate, enuatrol are conventional lubricants.With the magnesium stearate is example, is lubricated agent screening, and is index with capsule filling situation, determines best lubricant.The results are shown in following table:
Lubricant quantity is investigated table as a result
| Medicated powder amount (part) | Lubricant (part) | The tablet character |
| 330 | Do not add magnesium stearate | Not smooth, be difficult for filling |
| 330 | Add 1 part of magnesium stearate | Easily fill smoothly, |
| 330 | Add 5 parts of magnesium stearate | Machine alarm during filling, medicated powder are too sliding |
Result of the test shows 1 part of adding magnesium stearate, can play good lubricant effect.
In order effectively to control the quality of product of the present invention, the inventor has also formulated method of quality control, comprises qualitative identification and assay two parts, is described below respectively.
Qualitative identification:
1) get preparation of the present invention, put microscopically and observe: pollen grain similar round or ellipse, diameter 43～66um, outer wall has gear-like protrusions, 3 germinal aperatures of tool.The resin canal fragment contains pale brown color secretions.Brown or the brownish red of body wall fragment has circular trichopore, diameter 8～24um, the bristle that the tool that has is different in size.The dark brownish red of irregular fine particle, glossy, the edge furvous.Nonglandular hair is unicellular, and is how cataclasm, and wall is extremely thick, lignify, and base portion expands like stone cell.Irregular shape fragment, colourless, glossy, there is circular nest hole on complete person surface, and most fragments edge is semi-annular shape, and projection is arranged.
2) get preparation 10g of the present invention, porphyrize adds methanol 30ml, and supersound process 30 minutes filters, and filtrate is as need testing solution.Other gets the ginsenoside Rg
1And Panax Notoginseng saponin R
1, add methanol and make the solution that every 1ml contains 1mg, in contrast product solution.Test according to thin layer chromatography, draw need testing solution 10 μ l, reference substance solution 5 μ l, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, (15: 40: 22: 10) lower floor's solution of placing 12 hours below 10 ℃ was developing solvent with chloroform-ethyl acetate-methanol-water, launch, take out, dry, spray is with 10% ethanol solution of sulfuric acid, and it is clear to be heated to the speckle colour developing at 105 ℃.In the test sample chromatograph, with the corresponding position of reference substance on, show the speckle of same color.
3) get preparation 10g of the present invention, porphyrize, the 50ml that adds diethyl ether, supersound process 20 minutes filters, and volatilizes, and residue adds ethanol 2ml makes dissolving, as need testing solution.Other gets Olibanum control medicinal material 1g, the 20ml that adds diethyl ether, and supersound process 10 minutes filters, and filtrate evaporate to dryness, residue add dehydrated alcohol 5ml makes dissolving, in contrast medical material solution.Test according to thin layer chromatography, draw need testing solution, each 5 μ l of control medicinal material solution, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, with petroleum ether (60～90 ℃) is developing solvent, launch, take out, dry, spray is with 10% ethanol solution of sulfuric acid of 5% vanillin, and it is clear to be heated to the speckle colour developing at 105 ℃.In the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, show the speckle of same color.
Assay:
1) assay of strychnine in the Semen Strychni
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; Acetonitrile-1% glacial acetic acid (10: 90) is a mobile phase, detects wavelength 254nm, column temperature: 40 ℃.Flow velocity is 1.0ml/min.Number of theoretical plate calculates by the strychnine peak should be not less than 2000.
It is an amount of that the preparation precision of reference substance solution takes by weighing the strychnine reference substance, adds mobile phase and make the solution that every 1ml contains 45 μ g, promptly.
Preparation 10g of the present invention is got in the preparation of need testing solution, and porphyrize is got 3g, and accurate the title decides, put in the conical flask, add ammonia 5ml, precision adds chloroform 50ml, claims to decide weight, water-bath reflux, extract, 60 minutes is put coldly, weighs, supply the weight that subtracts mistake with chloroform, filter, precision is measured subsequent filtrate 25ml, water bath method, residue quantitatively is transferred in the 25ml measuring bottle with mobile phase, shakes up, filter with microporous filter membrane (0.45 μ m), get subsequent filtrate, promptly.
Accurate respectively reference substance and each the 10 μ l of need testing solution of drawing of algoscopy inject chromatograph of liquid, measure, promptly.
This product per unit amount contains Semen Strychni Pulveratum with strychnine (C
21H
22N
2O
2) meter, between 0.156～0.223mg.
2) assay of cinnabar
Get the about 10g of preparation powder of the present invention, the accurate title, decide, put in the kjeldahl flask, add sulphuric acid 50ml and potassium nitrate 5g, heating makes dissolving, put cold, add water 50ml, and add 1% potassium permanganate solution, drip 2% copperas solution again to red the disappearance to showing pink, add ammonium ferric sulfate indicator 2ml, with ammonium thiocyanate volumetric solution (0.1mol/L) titration.Every 1ml ammonium thiocyanate volumetric solution (0.1mol/L) is equivalent to the cinnabar (HgS) of 11.63mg.
This product per unit amount contains Cinnabaris in cinnabar (HgS), between 9.629mg～13.570mg.
Above-mentioned unit quantity is meant the finished medicines dosage that contains suitable 0.302g crude drug.
The specific embodiment
Pharmaceutical preparation of the present invention has blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, and the function of Shujin bone strengthening, the inventor cures mainly according to its function, from union of fracture, antiinflammatory, pain relieving aspect its pharmacodynamics is studied.
Be subjected to the reagent thing: the JG capsule that makes according to two kinds of preparation methoies of the present invention No. 1, No. 2, every contains crude drug 0.302g.
GUSHANG JIAONANG: Beijing institute of traditional Chinese medicine orthopedics department provides lot number: 031125.
Animal: rabbit: commercially available rabbit, body weight 2.0～3.0kg, male and female are not limit, Kunming mouse 18～22g, male and female dual-purpose, SD rat male and female half and half, 150～200g; Provide by new drug research center animal housing of China Medicine University.
GUSHANG JIAONANG, people's consumption are 6g/d, and the rabbit consumption is 12g/d, medicated powder is added in the rabbit feedstuff, and mixing, administration, the mouse stomach consumption is 3.2g/kg.w; The rat oral gavage consumption is 2.0g/kg.w.JG capsule, rabbit consumption are 8 JG capsule/d:100g feedstuffs.
Test 1: to the influence of rabbit experiment fracture experiment:
Get 40 of rabbit, under the sterile working, with bone saw cross saw bone, cause the bone of 4mm damaged in rabbit radius stage casing, sew up wrapping, postoperative is given penicillin 50,000 a units/intramuscular injection, for three days on end, takes out stitches after the 4th day.On the same day after operation, animal is divided into 4 groups at random: blank group, GUSHANG JIAONANG group and JG are with 1 group in capsule, 2 groups.Begin to give the pastille feedstuff simultaneously, blank group is given normal diet, and each was organized in the 1st week of postoperative, the 3rd week, takes the photograph the positive bit slice of operation limb X line in the 5th week, 7 weeks, puts to death 6 in the 25th day and the 50th day each group and draws materials and do the bone pathology inspection.
The X ray examination the results are shown in Table 1, table 2.
Table 1 bony union degree (meansigma methods or level)
| Group | Observing time (w) | |||
| 1 | 3 | 5 | 7 | |
| The blank group | I | II | III | III-IV |
| The GUSHANG JIAONANG group | I | II-III | III-IV | IV |
| No. 1, JG capsule | I | II-III | III-IV | IV |
| No. 2, JG capsule | I | II-III | III-IV | IV |
The table 2 clinical healing time (X ± S)
| Group | The example number | Clinical healing |
| The blank group | 10 | 46.3±3.9 |
| The GUSHANG JIAONANG group | 10 | 36.1±5.6 * |
| No. 1, JG capsule | 10 | 34.7±4.2 * |
| No. 2, JG capsule | 10 | 34.9±5.3 * |
Compare with matched group
*P＜0.05, GUSHANG JIAONANG group and JG Capsules group be p＞0.05 relatively.
Histological examination was put to death animal on the 25th day, and capsular osteoblast of GUSHANG JIAONANG and JG and bone trabecula are all more than the blank group, and osteoclast is less than matched group, and GUSHANG JIAONANG has 2/5, and the JG Capsules group has 1/5, and matched group has 1/2 not reach bony union.Put to death animal at the 49th day, three administration groups all reach bony union, and matched group still has 2/5 for reaching bony union.Experimental result shows that the JG capsule has the promotion callus formation, shortens the effect of healing time.
Test 2: analgesic experiment
The mice hot plate method, constant temperature box temperature is controlled at 55 ± 0.5 ℃ automatically, white mice is placed on the hot plate box, adding metapedes with the mice mouth is the pain reaction index, select 40 of the male mice of the threshold of pain between 10～25s, be divided into 4 groups at random, continuous gastric infusion is 3 days respectively, each mice pain threshold is write down in the different time test after the last administration.The results are shown in Table 3.Experimental result shows that the JG capsule all has analgesic activity preferably 1-2 number.
Table 3 analgesic activity (x ± s)
| Group | n | Dosage (g/kg) | The preceding threshold of pain of medication | Different time after the medication (min) threshold of pain | ||
| 30 | 60 | 120 | ||||
| The blank group | 10 | 19.85±1.95 | 4.01±2.56 | 2.49±1.74 | 2.13±1.21 | |
| The aspirin group | 10 | 0.2 | l7.97±2.26 | 25.84±1251 * | 20.63±15.52 * | 14.32±6.32 * |
| No. 1, JG capsule | 10 | 6.2 | 18.84±1.98 | 9.16±375 ** | 11.25±4.84 ** | 14.32±7.16 * |
| No. 2, JG capsule | 10 | 6.2 | 19.12±2.74 | 9.05±4.12 ** | 10.76±5.83 ** | 13.97±7.49 * |
Compare with matched group
*P＜0.05,
*P＜0.01.
Test 3: to the bullate influence of rat granuloma:
Get 40 of rats, be divided into 4 groups at random, with making abdominal incision under the ether light anaesthesia aseptic condition, with the cotton balls of having weighed, through high temperature sterilize, each cotton balls adds ampicillin 1mg/0.1ml again, after 50 ℃ of bakings were done, it was subcutaneous to implant rat both sides groin, begins gastric infusion the same day, matched group is given distilled water, continuous 7 days, the rat haircut is put to death in the 8th day, peel off and take out the cotton balls granulation tissue, weigh after the oven dry, deduct raw cotton autumn weight, be granulomatous weight.
The bullate influence of table 4 pair rat granuloma (X ± s)
| Group | n | Dosage (g/kg) | Granuloma heavy (g) |
| The blank group | 1O | 132.4±5.9 | |
| The GUSHANG JIAONANG group | 10 | 2 | 109.6±8.5 * |
| No. 1 group of JG capsule | 10 | 2.48 | 110.3±7.3 * |
| No. 2 groups of JG capsule | 10 | 2.48 | 108.4±8.3 * |
Make comparisons with the blank group,
*P＜0.05.
The granulomatous formation of rat has reflected the weight of inflammation, GUSHANG JIAONANG and JG capsule 1-2 number, and it is heavy obviously to reduce granuloma, thereby has tangible antiinflammatory action.
Test 4: acute toxicity test
Get 20 of mices, behind fasting 12h, press 40ml/kg and irritate stomach, observed 7 days, note observing acute toxic reaction whether occurs, the result does not find toxic reactions such as obvious spasm, lethargy, diarrhoea with Cmax (24.8gJG capsule medicated powder is dissolved in the 40ml water).
Further illustrate technical scheme of the present invention with specific embodiment more below:
Embodiment one
Prescription Flos Carthami 8g Eupolyphaga Seu Steleophaga 36g Cinnabaris 15g
Semen Strychni Pulveratum 25g Myrrha 6g Radix Notoginseng 60g
Asterias amurensis Lutken 18g Os Gallus domesticus 40g Borneolum Syntheticum 2g
Pyritum 15g Olibanum 5g Semen Melo 3g.
The above flavour of a drug of method for making are fine powder with Eupolyphaga Seu Steleophaga, Pyritum, Olibanum, Myrrha jointly, cross 100 mesh sieves, and are standby.Cinnabaris is worn into impalpable powder, cross 160 mesh sieves, standby.Flos Carthami, Radix Notoginseng, Asterias amurensis Lutken, Os Gallus domesticus, Semen Melo are ground into coarse granule, decoct with water twice, each 2 hours, to filter, filtrate merges, and is evaporated to the thick paste of 1.30 ℃ of relative densities, drying under reduced pressure, the gained dried cream powder is broken into fine powder, crosses 100 mesh sieves.With three parts of fine powders and the abundant mix homogeneously of 700g lactose, with the medicated powder of mix homogeneously, granulate with 50% alcoholic solution of 1% hydroxypropyl methylcellulose, dry (60 ℃), and granulate adds Borneolum Syntheticum, and lactose is 848g to total amount in right amount, mixing.Pack is made 212 bags, promptly.
Embodiment two
Prescription Flos Carthami 12g Eupolyphaga Seu Steleophaga 40g Cinnabaris 10g
Semen Strychni Pulveratum 20g Myrrha (processing) 4g Radix Notoginseng 80g
Asterias amurensis Lutken (processing) 20g Os Gallus domesticus (processing) 40g Borneolum Syntheticum 2g
Pyritum (forging) 20g Olibanum (processing) 4g Semen Melo 4g.
The above flavour of a drug of method for making with Flos Carthami and starch 4g, add water and make pasty state, mix thoroughly, and dry back is a fine powder with Radix Notoginseng, Asterias amurensis Lutken, Eupolyphaga Seu Steleophaga, Os Gallus domesticus, Pyritum, Olibanum, Myrrha, Semen Melo jointly, crosses 100 mesh sieves, and is standby.Cinnabaris is worn into impalpable powder, cross 160 mesh sieves.With Semen Strychni Pulveratum, Cinnabaris powder,, be blended in the standby fine powder of all medicines in the prescription ratio, fully mix homogeneously with the medicated powder of mix homogeneously, is granulated with 50% alcoholic solution of 1% hydroxypropyl methylcellulose, dry (60 ℃), granulate, it is an amount of to add Borneolum Syntheticum, magnesium stearate 1g and starch, to total amount be 297g, mixing, encapsulated, make 848, promptly.
Embodiment three
The method of quality control of the capsule that the invention described above compositions is made:
Differentiate:
A. get this product, put microscopically and observe, pollen grain similar round or ellipse, diameter 43～66um, outer wall have the gear projection, 3 germinal aperatures of tool.Brown or the brownish red of body wall fragment has circular trichopore, diameter 8～24um, the bristle that the tool that has is different in size.
B. get this product content 10g, porphyrize adds methanol 30ml, and supersound process 30 minutes filters, and filtrate is as need testing solution.Other gets the ginsenoside Rg
1And Panax Notoginseng saponin R
1, add methanol and make the solution that every 1ml contains 1mg, in contrast product solution.Test according to thin layer chromatography, draw need testing solution 10 μ l, reference substance solution 5 μ l, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, (15: 40: 22: 10) lower floor's solution of placing 12 hours below 10 ℃ was developing solvent with chloroform-ethyl acetate-methanol-water, launch, take out, dry, spray is with 10% ethanol solution of sulfuric acid, and it is clear to be heated to the speckle colour developing at 105 ℃.In the test sample chromatograph, with the corresponding position of reference substance on, show the speckle of same color.
C. get this product content 10g, porphyrize, the 50ml that adds diethyl ether, supersound process 20 minutes filters, and volatilizes, and residue adds ethanol 2ml makes dissolving, as need testing solution.Other gets Olibanum control medicinal material 1g, the 20ml that adds diethyl ether, and supersound process 10 minutes filters, and filtrate evaporate to dryness, residue add dehydrated alcohol 5ml makes dissolving, in contrast medical material solution.Test according to thin layer chromatography, draw need testing solution, each 5 μ l of control medicinal material solution, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, with petroleum ether (60～90 ℃) is developing solvent, launch, take out, dry, spray is with 10% ethanol solution of sulfuric acid of 5% vanillin, and it is clear to be heated to the speckle colour developing at 105 ℃.In the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, show the speckle of same color.
Assay:
A. the assay of strychnine in the Semen Strychni
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; Acetonitrile-1% glacial acetic acid (10: 90) is a mobile phase, detects wavelength 254nm, column temperature: 40 ℃.Flow velocity is 1.0ml/min.Number of theoretical plate calculates by the strychnine peak should be not less than 2000.
It is an amount of that the preparation precision of reference substance solution takes by weighing the strychnine reference substance, adds mobile phase and make the solution that every 1ml contains 45 μ g, promptly.
The preparation of need testing solution gets that this product 20 intragranulars are tolerant, and porphyrize is got 3g, accurate claim fixed, put in the conical flask, add ammonia 5ml, precision adds chloroform 50ml, claims to decide weight, water-bath reflux, extract, 60 minutes is put coldly, weighs, supply the weight that subtracts mistake with chloroform, filter, precision is measured subsequent filtrate 25ml, water bath method, residue quantitatively is transferred in the 25ml measuring bottle with mobile phase, shakes up, filter with microporous filter membrane (0.45 μ m), get subsequent filtrate, promptly.
Accurate respectively reference substance and each the 10 μ l of need testing solution of drawing of algoscopy inject chromatograph of liquid, measure, promptly.
Every of this product contains Semen Strychni Pulveratum with strychnine (C
21H
22N
2O
2) meter, between 0.156～0.223mg.
B. the assay of cinnabar
The assay of cinnabar in the Cinnabaris
Get the about 10g of this product powder, the accurate title, decide, put in the kjeldahl flask, add sulphuric acid 50ml and potassium nitrate 5g, heating makes dissolving, put cold, add water 50ml, and add 1% potassium permanganate solution, drip 2% copperas solution again to red the disappearance to showing pink, add ammonium ferric sulfate indicator 2ml, with ammonium thiocyanate volumetric solution (0.1mol/L) titration.Every 1ml ammonium thiocyanate volumetric solution (0.1mol/L) is equivalent to the cinnabar (HgS) of 11.63mg.
Every of this product contains Cinnabaris in cinnabar (HgS), between 9.629mg～13.570mg.
Above-mentioned every is meant the capsule that contains suitable 0.302g crude drug.
Claims (10)
1. Chinese medicine composition is characterized in that said composition made by following raw material medicaments:
A kind of Chinese medicine composition is characterized in that said composition made by following raw material medicaments:
Flos Carthami 5-15 weight portion Eupolyphaga Seu Steleophaga 30-50 weight portion Cinnabaris 5-15 weight portion
Semen Strychni Pulveratum 15-30 weight portion Myrrha 3-6 weight portion Radix Notoginseng 60-100 weight portion
Asterias amurensis Lutken 15-30 weight portion Os Gallus domesticus 30-60 weight portion Borneolum Syntheticum 1-3 weight portion
Pyritum 15-30 weight portion Olibanum 1-5 weight portion Semen Melo 1-5 weight portion.
2. Chinese medicine composition as claimed in claim 1 is characterized in that this Chinese medicine composition made by following raw materials according:
Flos Carthami 12 weight portion Eupolyphaga Seu Steleophagas 40 weight portion Cinnabaris 10 weight portions
Semen Strychni Pulveratum 20 weight portion Myrrhas 4 weight portion Radix Notoginseng 80 weight portions
Asterias amurensis Lutken 20 weight portion Os Gallus domesticus 40 weight portion Borneolum Syntheticums 2 weight portions
Pyritum 20 weight portion Olibanums 4 weight portion Semen Melos 4 weight portions.
3. Chinese medicine composition as claimed in claim 1 or 2 is characterized in that Myrrha, Asterias amurensis Lutken, Os Gallus domesticus, the Olibanum in the crude drug is the product of processing, and Pyritum then is a Pyritum (calcined).
4. Chinese medicine composition as claimed in claim 3 is characterized in that this Chinese medicine composition can be prepared into granule, capsule, pill.
5. the preparation method of the described Chinese medicine composition of claim 4 is characterized in that this method comprises one of following two kinds of methods:
1) will write out a prescription in Flos Carthami and starch 4 weight portions, add water and make pasty state, mix thoroughly, dry back be the porphyrize powder with Radix Notoginseng, Asterias amurensis Lutken, Eupolyphaga Seu Steleophaga, Os Gallus domesticus, Pyritum, Olibanum, Myrrha, Semen Melo jointly, mistake 100 mesh sieves are standby; Cinnabaris is worn into impalpable powder, cross 160 mesh sieves; With Semen Strychni Pulveratum, Cinnabaris powder, in the prescription ratio, be blended in the standby fine powder of all medicines, fully mix homogeneously is granulated, and adds Borneolum Syntheticum during granulate, and mixing gets mixture;
2) will write out a prescription in Eupolyphaga Seu Steleophaga, Pyritum, Olibanum, Myrrha, grind and be fine powder jointly, cross 100 mesh sieves, standby; Cinnabaris is worn into impalpable powder, cross 160 mesh sieves, standby; Flos Carthami, Radix Notoginseng, Asterias amurensis Lutken, Os Gallus domesticus, Semen Melo are ground into coarse granule, decoct with water twice, each 2 hours, to filter, filtrate merges, and is evaporated to the thick paste of 1.30 ℃ of relative densities, drying under reduced pressure, the gained dried cream powder is broken into fine powder, crosses 100 mesh sieves; With three parts of abundant mix homogeneously of fine powder, granulate, add Borneolum Syntheticum during granulate, mixing gets mixture.
6. the preparation method of Chinese medicine composition as claimed in claim 5 is characterized in that the mixture that will obtain at last adding conventional adjuvant, makes required dosage form, comprises granule, capsule and pill.
7. the preparation method of Chinese medicine composition as claimed in claim 6, the conventional adjuvant that it is characterized in that said adding is meant that in starch, carboxymethylstach sodium, cross-linking sodium carboxymethyl cellulose, polyvidone, polyvinylpolypyrrolidone, Explotab, low-substituted hydroxypropyl cellulose, the alginic acid one or more are as disintegrating agent; In different concentration ethanol, water, starch slurry, dextrin, high-purity dextrin slurry, starch and sucrose mixing slurry, starch and arabic gum mixing slurry, mucialga of arabic gummy, syrup, maltose, gelatine size, polyvinylpyrrolidone, Polyethylene Glycol, methylcellulose, sodium carboxymethyl cellulose, ethyl cellulose, hydroxypropyl cellulose, the sucrose dextrin copolymer one or more are as binding agent; Stearic acid and calcium thereof, magnesium, zinc salt, micropowder silica gel, hydrogenated vegetable oil, sodium laurylsulfate, magnesium laurylsulfate, single Laurel sucrose acid ester, adipic acid, fumaric acid, triacetyl glycerine, Macrogol 4000, polyethylene glycol 6000, Polyethylene Glycol 8000, polyoxyethylene monostearate, light mineral oil, liquid Paraffin, the wax class, boric acid, sodium chloride, sodium benzoate, sodium acetate, one or more in the enuatrol are as lubricant.
8. as the method for quality control of claim 1,2 or 3 described Chinese medicine compositions, it is characterized in that this method comprises one or more following discrimination methods:
1) get preparation of the present invention, can be observed pollen grain similar round or ellipse at microscopically, diameter 43～66um, outer wall has gear-like protrusions, 3 germinal aperatures of tool; The resin canal fragment contains pale brown color secretions; Brown or the brownish red of body wall fragment has circular trichopore, diameter 8～24um, the bristle that the tool that has is different in size; The dark brownish red of irregular fine particle, glossy, the edge furvous; Nonglandular hair is unicellular, and is how cataclasm, and wall is extremely thick, lignify, and base portion expands like stone cell; Irregular shape fragment, colourless, glossy, there is circular nest hole on complete person surface, and most fragments edge is semi-annular shape, and projection is arranged;
2) get claim 5 gained mixture 10g of the present invention, porphyrize adds methanol 30ml, and supersound process 30 minutes filters, and filtrate is as need testing solution; Other gets ginsenoside Rg1 and arasaponin R1, adds methanol and makes the solution that every 1ml contains 1mg, in contrast product solution; Test according to thin layer chromatography, draw need testing solution 10 μ l, reference substance solution 5 μ l, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, with 15: 40: 22: lower floor's solution that chloroform-ethyl acetate of 10-methanol-water was placed 12 hours below 10 ℃ was developing solvent, launch, take out, dry, spray is with 10% ethanol solution of sulfuric acid, and it is clear to be heated to the speckle colour developing at 105 ℃; In the test sample chromatograph, with the corresponding position of reference substance on, show the speckle of same color;
3) get claim 5 gained mixture 10g of the present invention, porphyrize, the 50ml that adds diethyl ether, supersound process 20 minutes filters, and volatilizes, and residue adds ethanol 2ml makes dissolving, as need testing solution; Other gets Olibanum control medicinal material 1g, the 20ml that adds diethyl ether, and supersound process 10 minutes filters, and filtrate evaporate to dryness, residue add dehydrated alcohol 5ml makes dissolving, in contrast medical material solution; Test according to thin layer chromatography, draw need testing solution, each 5 μ l of control medicinal material solution, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, with the petroleum ether is developing solvent, launch, take out, dry, spray is with 10% ethanol solution of sulfuric acid of 5% vanillin, and it is clear to be heated to the speckle colour developing at 105 ℃; In the test sample chromatograph, with the corresponding position of control medicinal material chromatograph on, show the speckle of same color.
9. the method for quality control of Chinese medicine composition as claimed in claim 8 is characterized in that also comprising in this method following a kind of or two kinds of content assaying methods:
1) assay of strychnine in the Semen Strychni
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; 10: 90 acetonitrile-1% glacial acetic acid is a mobile phase, detects wavelength 254nm, column temperature: 40 ℃; Flow velocity is 1.0ml/min; Number of theoretical plate calculates by the strychnine peak should be not less than 2000;
It is an amount of that the preparation precision of reference substance solution takes by weighing the strychnine reference substance, adds mobile phase and make the solution that every 1ml contains 45 μ g, promptly;
Claim 5 gained mixture 10g of the present invention is got in the preparation of need testing solution, and porphyrize is got 3g, and accurate the title decides, put in the conical flask, add ammonia 5ml, precision adds chloroform 50ml, claims to decide weight, water-bath reflux, extract, 60 minutes is put coldly, weighs, supply the weight that subtracts mistake with chloroform, filter, precision is measured subsequent filtrate 25ml, water bath method, residue quantitatively is transferred in the 25ml measuring bottle with mobile phase, shakes up, microporous filter membrane with 0.45 μ m filters, and gets subsequent filtrate, promptly;
Accurate respectively reference substance and each the 10 μ l of need testing solution of drawing of algoscopy inject chromatograph of liquid, measure, promptly.
2) assay of cinnabar
Get claim 5 gained mixture 10g of the present invention, the accurate title, decide, and puts in the kjeldahl flask, adds sulphuric acid 50ml and potassium nitrate 5g, heating makes dissolving, put coldly, add water 50ml, and add 1% potassium permanganate solution to showing pink, drip 2% copperas solution again to red the disappearance, add ammonium ferric sulfate indicator 2ml, with the ammonium thiocyanate volumetric solution titration of 0.1mol/L, every 1ml ammonium thiocyanate volumetric solution is equivalent to the cinnabar of 11.63mg.
10. treat traumatic injury as claim 1,2 or 3 described Chinese medicine compositions in preparation, lumbar sprain and QI divergeny, injured in the sinews or bones, swelling and pain due to blood stasis, the application in the disease drugs such as damage redness.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005102000435A CN1316990C (en) | 2005-01-18 | 2005-01-18 | Chinese medicinal composition, preparation method and quality control method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005102000435A CN1316990C (en) | 2005-01-18 | 2005-01-18 | Chinese medicinal composition, preparation method and quality control method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1806820A true CN1806820A (en) | 2006-07-26 |
| CN1316990C CN1316990C (en) | 2007-05-23 |
Family
ID=36839030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005102000435A Expired - Fee Related CN1316990C (en) | 2005-01-18 | 2005-01-18 | Chinese medicinal composition, preparation method and quality control method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1316990C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100361667C (en) * | 2005-07-08 | 2008-01-16 | 大连美罗中药厂有限公司 | Medicine for treating traumatology diseases, and its preparing method |
| CN100408055C (en) * | 2006-03-15 | 2008-08-06 | 北京凯瑞创新医药科技有限公司 | Chinese medicinal composition for treating traumatic diseases, its preparation method and quality control method |
| CN101278976B (en) * | 2008-05-30 | 2010-10-20 | 大连美罗中药厂有限公司 | Quality control method of Shangke bone-knitting medicine |
| CN101380362B (en) * | 2008-10-24 | 2011-08-10 | 大连美罗中药厂有限公司 | Quality control method of volatile ingredients fingerprint of bone knitting medicine of traumatology |
| CN105106521A (en) * | 2015-10-16 | 2015-12-02 | 韩守江 | Analgesic for traumatic injuries |
| CN108195778A (en) * | 2017-12-28 | 2018-06-22 | 大工（青岛）新能源材料技术研究院有限公司 | The detection method of low concentration copper ion in a kind of waste water |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1362122A (en) * | 2001-01-04 | 2002-08-07 | 杨孟君 | Nano fracture-setting traumatic medicine and its preparation |
-
2005
- 2005-01-18 CN CNB2005102000435A patent/CN1316990C/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100361667C (en) * | 2005-07-08 | 2008-01-16 | 大连美罗中药厂有限公司 | Medicine for treating traumatology diseases, and its preparing method |
| CN100408055C (en) * | 2006-03-15 | 2008-08-06 | 北京凯瑞创新医药科技有限公司 | Chinese medicinal composition for treating traumatic diseases, its preparation method and quality control method |
| CN101278976B (en) * | 2008-05-30 | 2010-10-20 | 大连美罗中药厂有限公司 | Quality control method of Shangke bone-knitting medicine |
| CN101380362B (en) * | 2008-10-24 | 2011-08-10 | 大连美罗中药厂有限公司 | Quality control method of volatile ingredients fingerprint of bone knitting medicine of traumatology |
| CN105106521A (en) * | 2015-10-16 | 2015-12-02 | 韩守江 | Analgesic for traumatic injuries |
| CN108195778A (en) * | 2017-12-28 | 2018-06-22 | 大工（青岛）新能源材料技术研究院有限公司 | The detection method of low concentration copper ion in a kind of waste water |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1316990C (en) | 2007-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1308012C (en) | Chinese medicine composition for treating cerebral hemorrhage and its prepn | |
| CN1899361A (en) | Zhenqi medicinal composition and its preparation | |
| CN1316990C (en) | Chinese medicinal composition, preparation method and quality control method thereof | |
| CN1201786C (en) | Traditional Chinese medicine composition for curing child's dyspepsia and cough and its preparing method | |
| CN101057925A (en) | Preparation technology for 'jieguqili' capsule and its quality control method | |
| CN106974952A (en) | Application of the fresh ginseng activity extract in treatment oral cavity and digestive tract ulcer medicine is prepared | |
| CN1709341A (en) | Medicinal composition for nourishing qi to invigorate spleen, and its preparing method and use | |
| CN1817898A (en) | Use of anti-inflammatory medicine for scheelite total saponin and its saponin compound | |
| CN102058822B (en) | Pharmaceutical composition for strengthening stomach and promoting digestion | |
| CN1741807A (en) | Anticulcer herbal composition(s) | |
| CN101040957A (en) | Medicine for treating skin diseases such as eczema and dermatitis and the method for preparing the same | |
| CN1286501C (en) | Medicine composition for treating stomach disease, its preparation method and use | |
| CN1292778C (en) | Chinese medicine composition for stopping itching and its preparing method | |
| CN1973878A (en) | Medicine for treating children's stomachache and its prepn | |
| CN1857285A (en) | Capsule for treating cardiac and cerebral vascular diseases and its preparing method and application | |
| CN1879799A (en) | Menstruation-regulating preparation with asiabell and cassia bark and method for preparing same | |
| CN1582952A (en) | Use of asiaticoside in preparation of medicines for diseases of cardio-cerebral blood vessels | |
| CN100408055C (en) | Chinese medicinal composition for treating traumatic diseases, its preparation method and quality control method | |
| CN101040891A (en) | Method of preparing tripterygium hypoglaucum (Levl) hutch alkaloids | |
| CN1186067C (en) | Medicine for curing acute injury of muscle and tendon and its preparation method | |
| CN106511394B (en) | Application of aspongopus fatty oil extract | |
| CN1241586C (en) | Chinese medicine composition and preparing method thereof | |
| CN1879711A (en) | A Chinese medicinal composition for treating gastric disease, its preparation process and quality control method | |
| CN1075950C (en) | Traditional Chinese medicine for treating gastropathy | |
| CN1201742C (en) | Hypoglycemic health-care food for diabetes type II; |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: LI DAOXIU Free format text: FORMER OWNER: BEIJING KAIRUI INNOVATION PHARMACEUTICAL TECHNOLOGY CO., LTD. Effective date: 20070803 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20070803 Address after: 110035 No. 8 Ming Lian Road, Huanggu District, Liaoning, Shenyang Patentee after: Li Daoxiu Address before: 100027, Beijing Haidian District Zhongguancun South Street No. 12 health center Patentee before: Beijing Kairui Chuangxin Pharmaceutical Sci. & Tech. Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070523 Termination date: 20170118 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |